ART

09h00 • INT165 • Introduction 09h15 • INT166 • Session 1: New players in allergic diseases 09h15 • INT167 • From IL-33 to TL1A: role of alarmin cytokines in the initiation of allergic airway inflammation > J-P. Jean-Philippe GIRARD (Toulouse) 10h00 • INT168 • IL-20 cytokines: Friend or foes in chronic airway diseases > M. Muriel PICHAVANT (Lille) 10h35 • INT169 • Does the Gut Microbiome mediate the impact of Lifestyle on metabolic Phenotypes? > K. Karine CLEMENT (Paris) 11h10 • INT170 • Coffee break 11h30 • INT171 • Session 2: New insights into the roles of basophils 11h30 • INT172 • Basophils as Gatekeepers: Amplifying Asthma Through IL-33-Driven Th2 Infiltration > M. Martijn SCHUIJS (Gent) 12h05 • INT173 • Basophils in the control of humoral autoimmunity > N. Nicolas CHARLES (Paris) 12h40 • INT174 • Lunch 13h40 • INT175 • Session 3: Immune mechanisms of allergic diseases 13h40 • INT176 • Peripheral neuroimmune interactions in allergic inflammation > N. Nicolas GAUDENZIO (Toulouse) 14h15 • INT177 • Mast cell-mediated immunosurveillance of the blood stream > A. Axel ROERS (Heidelberg) 14h50 • INT178 • Billions of neutrophils: Exploring the multiple facets of neutrophils in lung homeostasis and allergic diseases > C. Coraline RADERMECKER (Liège) 15h25 • INT179 • Coffee break 15h45 • INT180 • Session 4: Novel targets in allergic diseases 15h45 • INT181 • CCL2 chemokine follows a complex bitemporal secretion pattern for local attraction during IgE-mediated mast cell activation > E. Eduardo MONTERO (Paris) 16h10 • INT182 • Artificial intelligence and biomarker-driven approaches in developing novel therapeutics for allergic diseases > M. Mohamed SHAMJI (London) 16h55 • INT183 • Concluding remarks > V. Virginie DOYEN (Yvoir), F. Frédéric BERARD (Lyon)